DEB025 doesn’t need to show great efficacy as monotherapy. Its function in HCV cocktails will be to add modest incremental efficacy without generating any mutant HCV strains whatsoever (because it targets a host protein).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”